235 related articles for article (PubMed ID: 36203601)
1. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.
Dai Z; Sezin T; Chang Y; Lee EY; Wang EHC; Christiano AM
Front Immunol; 2022; 13():955038. PubMed ID: 36203601
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
Dai Z; Chen J; Chang Y; Christiano AM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
[TBL] [Abstract][Full Text] [Related]
4. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
Lensing M; Jabbari A
Front Immunol; 2022; 13():955035. PubMed ID: 36110853
[TBL] [Abstract][Full Text] [Related]
5. The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.
Ge T; Jhala G; Fynch S; Akazawa S; Litwak S; Pappas EG; Catterall T; Vakil I; Long AJ; Olson LM; Krishnamurthy B; Kay TW; Thomas HE
Front Immunol; 2020; 11():588543. PubMed ID: 33343569
[TBL] [Abstract][Full Text] [Related]
6. Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.
Sardana K; Bathula S; Khurana A
Indian Dermatol Online J; 2023; 14(4):465-474. PubMed ID: 37521227
[TBL] [Abstract][Full Text] [Related]
7. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T-cell activity in alopecia areata: recent developments and new directions.
Passeron T; King B; Seneschal J; Steinhoff M; Jabbari A; Ohyama M; Tobin DJ; Randhawa S; Winkler A; Telliez JB; Martin D; Lejeune A
Front Immunol; 2023; 14():1243556. PubMed ID: 38022501
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
[TBL] [Abstract][Full Text] [Related]
12. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.
Crowley EL; Fine SC; Katipunan KK; Gooderham MJ
J Cutan Med Surg; 2019; 23(3):289-297. PubMed ID: 30688081
[TBL] [Abstract][Full Text] [Related]
13. Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway.
He X; Liu J; Gong Y; Lu W; Sha X; Cao C; Li Y; Wang J
J Ethnopharmacol; 2024 Sep; 331():118317. PubMed ID: 38723918
[TBL] [Abstract][Full Text] [Related]
14. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata.
de Jong A; Jabbari A; Dai Z; Xing L; Lee D; Li MM; Duvic M; Hordinsky M; Norris DA; Price V; Mackay-Wiggan J; Clynes R; Christiano AM
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282836
[TBL] [Abstract][Full Text] [Related]
15. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.
Mackay-Wiggan J; Jabbari A; Nguyen N; Cerise JE; Clark C; Ulerio G; Furniss M; Vaughan R; Christiano AM; Clynes R
JCI Insight; 2016 Sep; 1(15):e89790. PubMed ID: 27699253
[No Abstract] [Full Text] [Related]
16. Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice.
Lee E; Kim M; Lee YJ
Front Immunol; 2022; 13():874778. PubMed ID: 35799786
[TBL] [Abstract][Full Text] [Related]
17. The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells.
Kim JE; Lee YJ; Park HR; Lee DG; Jeong KH; Kang H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698510
[TBL] [Abstract][Full Text] [Related]
18. Alopecia Areata: New Treatment Options Including Janus Kinase Inhibitors.
Zheng C; Tosti A
Dermatol Clin; 2021 Jul; 39(3):407-415. PubMed ID: 34053594
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?
Dainichi T; Iwata M; Kaku Y
J Dermatol; 2024 Feb; 51(2):196-209. PubMed ID: 38087654
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3 Gallate Inhibits
Hamed FN; McDonagh AJG; Almaghrabi S; Bakri Y; Messenger AG; Tazi-Ahnini R
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30558329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]